PD-1 expression on T cells was also more frequent in patients with relapsed AML, and postanalysis of AML specimens showed that the hypomethylation status of the PD-L1 and PD-L2 gene promoters in leukemia cells was an independent negative prognostic factor [153]. The gene discussed is PDCD1LG2; the disease is acute myeloid leukemia.